The biomaterials/regenerative medicine industry, usually lumped under the title of
“biofabrication,” involves two separate but overlapping areas of research.
Regenerative medicine is defined by therapies that are meant to regenerate or replace human
cells to restore/establish typical function. This includes cell and gene therapies as well as
scaffold placement and 3D-fabricated organs.
Biomaterials is a broader term, and encompasses any material, synthetic or biologic, that is
used to reconstruct or replace tissues. This also includes tissue-like material that is derived from
biology — currently that’s mainly fabrics and some plastics (more trendy, bio-art stuff). The
definition is evolving, and some use it when describing biofuel/biochemical companies also.